Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
4450 Cousens , Montreal, QC, H4S 1X6, CA
Plan includes expanding the site, installing a new filling line, and upgrading existing equipment to comply with new Health Canada standards.
By: Charlie Sternberg
The approval follows an inspection by the cell and gene therapy experts from Health Canada.
Development and submission of labels and regulatory filings to support compliance with new FDA & Health Canada Standards.
By: Kristin Brooks
Marks a significant milestone for Almac Pharma Services’ Audubon, PA site.
COVIFENZ uses plant-based virus-like particles [VLP] technology and vaccine co-administered with GSK’s pandemic adjuvant.
The CDMO created a virtual tour of its facilities in response to the pandemic.
By: Tim Wright
Mississauga site is the company’s first manufacturing facility in North America and is its HQ in the region.
Pfizer Canada and BioNTech will supply the Government of Canada a minimum of 20 million doses and up to 76 million doses of the vaccine through 2021.
By: Contract Pharma
Canadian regulator authorizes supply and emergency use of Pfizer and BioNTech’s COVID-19 mRNA vaccine.
Begins development of cannabis-based veterinary drug products in Montreal
Receives license amendment from Health Canada Cannabis Regulation approving sale of cGMP cannabis derived products to License Holders.
To manufacture a monoclonal antibody drug substance at its first plant
Inspection covered sterile and non-sterile drug products, APIs and more
Pillar5 Pharma, Inc. recently underwent a successful GMP inspection by Health Canada.
Dalton Pharma Services has successfully completed its Health Canada audit and has received a 'compliant' rating for its GMP manufacturing facility.
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
